BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 16482599)

  • 1. Could a high resectability rate improve the long-term survival of patients with proximal bile duct cancer?
    Veroux M; Madia C; Fiamingo P; CagliĆ  P; Valastro M; Amodeo C; Veroux P; Gagliano M; Basso S; D'Amico DF
    J Surg Oncol; 2006 Mar; 93(3):199-205. PubMed ID: 16482599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hepatectomy in the treatment of hilar bile duct carcinoma.
    Tsuchikawa T; Kondo S; Hirano S; Tanaka E; Anbo Y; Morikawa T; Okushiba S; Katoh H
    Surg Today; 2004; 34(5):405-8. PubMed ID: 15108077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is it possible to improve survival in patients with Klatskin tumors?].
    Veroux M; Madia C; Bruno G; Fiamingo P; D'Erminio A; Amodeo C; CagliĆ  P; Veroux P; D'Amico DF
    Tumori; 2003; 89(4 Suppl):162-5. PubMed ID: 12903580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic bile duct carcinoma: a western experience with 118 consecutive patients.
    Doglietto GB; Alfieri S; Pacelli F; Mutignani M; Costamagna G; Carriero C; Di Giorgio A; Papa V
    Hepatogastroenterology; 2000; 47(32):349-54. PubMed ID: 10791187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experiences of hilar skeletonization for the treatment of locally advanced proximal bile duct cancer.
    Kim MW; Kim WH; Wang HJ; Chung JB; Chun M
    Hepatogastroenterology; 2001; 48(41):1298-301. PubMed ID: 11677950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognosis and treatment of bile duct carcinoma.
    Chung C; Bautista N; O'Connell TX
    Am Surg; 1998 Oct; 64(10):921-5. PubMed ID: 9764692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group.
    Sugiura Y; Nakamura S; Iida S; Hosoda Y; Ikeuchi S; Mori S; Sugioka A; Tsuzuki T
    Surgery; 1994 Apr; 115(4):445-51. PubMed ID: 8165536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative treatment for bile duct carcinoma.
    Safioleas M; Mantas D; Kakisis J; Manti C; Kouraklis G; Kostakis A
    Hepatogastroenterology; 2003; 50(51):636-8. PubMed ID: 12828049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of pT2 gallbladder carcinoma: a reevaluation of the therapeutic effect of hepatectomy and extrahepatic bile duct resection based on the long-term outcome.
    Yokomizo H; Yamane T; Hirata T; Hifumi M; Kawaguchi T; Fukuda S
    Ann Surg Oncol; 2007 Apr; 14(4):1366-73. PubMed ID: 17260109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term results of 84 surgically treated patients with extrahepatic bile duct carcinoma].
    Zheng SS; Qin YS; Liang TB; Huang DS; Zhang M; Wang WL; Shen Y; Wang JH
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):554-6. PubMed ID: 16438856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of hilar bile duct carcinoma.
    Bathe OF; Pacheco JT; Ossi PB; Hamilton KL; Franceschi D; Sleeman D; Levi JU; Livingstone AS
    Hepatogastroenterology; 2001; 48(41):1289-94. PubMed ID: 11677948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical treatment of type IV choledochal cysts.
    Kawarada Y; Das BC; Tabata M; Isaji S
    J Hepatobiliary Pancreat Surg; 2009; 16(5):684-7. PubMed ID: 19370303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
    Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
    Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical treatment for carcinoma at the confluence of the major hepatic ducts.
    Iwasaki Y; Okamura T; Ozaki A; Todoroki T; Takase Y; Ohara K; Nishimura A; Otsu H
    Surg Gynecol Obstet; 1986 May; 162(5):457-64. PubMed ID: 3704902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aggressive surgical treatment for cholangiocarcinoma].
    Shimonov M; Schecter P; Avni Y; Rabin E; Rosen A; Czerniak A
    Harefuah; 2001 Jun; 140(6):479-82, 566. PubMed ID: 11420845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
    Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
    Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Palliative cholangiojejunostomy on the duct of hepatic segment III. Our experience].
    Confalonieri F; Ballerini A
    Minerva Chir; 1998 Sep; 53(9):709-14. PubMed ID: 9866936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggressive surgical resection for hilar cholangiocarcinoma.
    Lai EC; Lau WY
    ANZ J Surg; 2005 Nov; 75(11):981-5. PubMed ID: 16336393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoma of the main hepatic duct junction: indications, operative morbidity and mortality, and long-term survival.
    Tsuzuki T; Ueda M; Kuramochi S; Iida S; Takahashi S; Iri H
    Surgery; 1990 Sep; 108(3):495-501. PubMed ID: 2396193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and an overview of decision-making in patients with cholangiocarcinoma.
    Forsmo HM; Horn A; Viste A; Hoem D; Ovrebo K
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):412-7. PubMed ID: 18693178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.